Skip to main content
09/10/2023 - 15:13

Radiopharm green-lighted for radioactive lung cancer trial

09/10/2023 - 15:13

Bookmark

Save articles for future reference.

The Human Research Ethics Committee has given Radiopharm Theranostics its stamp of approval to begin first-in-human phase-one dose escalation trials in Australia on patients living with non-small cell lung cancer. The company says the vital approval will allow it to pursue greater hope for patients dealing with a devastating condition that currently has a “poor prognosis” in terms of life expectancy.

X